Posts by Jason H. Wasfy, MD
U.S. COVID-19 Test Results Strongly Correlate with Race/Ethnicity, Income
By reviewing data on 394,536 people tested for COVID-19 before vaccines became available, physicians at Massachusetts General Hospital confirmed that among tested patients, low-income patients and people of color in the US are more likely to have been infected.
Role of Cardiologists in Evaluation of Type 2 Myocardial Infarction Unclear
Cian P. McCarthy, MB, BCh, BAO, and Jason H. Wasfy, MD, MPhil, of the Division of Cardiology, documented significant differences in testing and treatment between patients with type 2 myocardial infarction who were or were not evaluated by a cardiologist during admission, but the effect on outcomes is still unclear.
Electronic Consultations Help Sustain Outpatient Care During the COVID-19 Pandemic
In the first months of the COVID-19 pandemic in Massachusetts, clinician-to-clinician electronic consultations at Massachusetts General Hospital increased substantially relative to in-person consultations.
Medical Grand Rounds: Cardiac Manifestations of COVID-19
On May 14, 2020, the tenth lecture in the Medical Grand Rounds' COVID-19 series featured a panel of experts who are investigating the cardiac manifestations of coronavirus. The panel included Mass General's Anthony Rosenzweig, MD, chief of cardiology, Jason Wasfy, MD, cardiologist, and Judy Hung, MD, cardiologist.
Better Prognostic Risk Scoring Needed for Patients with Type 2 Myocardial Infarction
In this first study of its kind, the GRACE, TIMI and TARRACO scores were at best only modestly predictive of adverse outcomes in patients with type 2 myocardial infarction.
No Gender Differences Found in Outcomes of Type 2 MI
In the first study of its kind, cardiologists found no differences between men and women at Massachusetts General Hospital with regard to treatment strategies or short-term outcomes of type 2 myocardial infarction.
Surgery for Isolated Severe Regurgitation Does Not Improve Survival
In patients with isolated severe tricuspid regurgitation, there is no difference in long-term survival for patients who undergo surgical intervention and those who have medical management alone.
ACC 2019: A Media Roundup
At the 2019 ACC Annual Meeting, cardiologists from Massachusetts General Hospital presented and discussed research findings and advances in clinical care, such as predicting and preventing adverse cardiovascular events and optimizing patient care.
Editorial: Angiotensin-Receptor/Neprilysin Inhibitors Deserve Wider Adoption
Commenting on a U.S. registry study, physicians at Massachusetts General Hospital note the low adoption of angiotensin-receptor/neprilysin inhibitors and suggest why value-based pricing might be a solution.
Leveraging Social Media in Medicine
A group from the Massachusetts General Hospital Corrigan Minehan Heart Center discusses how they leverage social media as both practicing clinicians and active researchers.
Position Paper: Distinguish Type 1 and Type 2 MI in Readmission Reduction Program
Noting the different patient characteristics, prognosis and management strategies for type 1 and type 2 myocardial infarction, cardiologists at Massachusetts General Hospital argue that the Medicare Hospital Readmission Reduction Program should not conflate the two.
Inadequate Surveillance of Valvular Disease May Help Explain Disparities in Outcomes
Black, female and older patients and patients on Medicaid are less likely to receive appropriate echocardiographic surveillance of valvular heart disease, per an analysis performed in the Cardiology Outcomes Research Group at Massachusetts General Hospital. They report their findings in a research letter in JACC: Cardiovascular Imaging.
Quality Improvement Informed by an Analytics-Driven System Reduces Hospital Readmissions and Improves Care
A Massachusetts General expert uses data analytics to improve the quality, value and delivery of cardiology care.
Improving Clinical Outcomes for Patients
Jason Wasfy, MD, medical director of the Massachusetts General Physicians Organization and the director of quality and analytics for the Mass General Heart Center, discusses his passion for fundamentally understanding the effects of public policy changes on clinical outcomes for patients. He also speaks to his desire to implement policies that are effective in improving clinical outcomes.
Gains in Republican Votes in the 2016 Presidential Election Linked with Poor Public Health
Trump’s Republican vote gains in 2016 presidential election have been significantly associated with poor public health.
#AHA17 Video: Scientific Sessions in Summary
Mass General physicians presented on the podium, moderated sessions or showcased posters over 50 times at the American Heart Association 2017 Scientific Sessions. Some of them answered the question: “What was the most interesting topic presented at this year’s Scientific Sessions?"
Dr. Wasfy is Director of Quality and Analytics as well as the Director for Outcomes Research for the Mass General Heart Center. He is a cardiologist in the Cardiac Unit Associates and an cardiac intensivist in the Cardiac Intensive Care Unit. He is also the medical director of the Massachusetts General Physicians Organization. His research focuses on health policy and outcomes in cardiology, focusing on safety and value for patients. Previously, he was the administrative fellow in cardiology and the Roman DeSanctis clinical scholar at the MGH. He holds the S.B. from MIT in chemical engineering (2001) and the M.D. from Harvard Medical School (2007). He also holds the M.Phil. from Oxford University (2003), where he was a Marshall Scholar.